Abstract:Background Endometrial carcinoma is one of the most common gynecological cancers and the incidence has been increasing. This study was to identify the relationship of estrogen receptor (ER), progestrone receptor (PR), P53 protein, Ki-67 and phosphatase and tensin homolog deleted on chromosome ten (PTEN) with endometrial carcinoma, the assessment of these biomarkers and their association with clinicopathological parameters was performed. Methods A total of 198 cases of primary endometrial carcinoma were investigated for ER, PR, Ki-67, P53, and PTEN antigens by immunohistochemical methods. The association of these markers with age, menopause status, histological type, FIGO stage, grading, depth of invasion, lymph node involvement and serum tumor marker was examined. Results The percentages of Ki-67- and P53-negative endometrial tumors were significantly higher in ER-positive compared with ER-negative tumors (both P =0.000). The same trend was evident with PR status. The percentage of PTEN-positive tumors was significantly higher in PR-positive compared with PR-negative tumors ( P =0.021), but was no difference in tumors with different ER status. There was no clear association between PTEN positivity and clinicopathological parameters except more relevance with endometrioid histotype ( P =0.013). There was a statistically significant difference in the distribution of the different combined biological factors examined in disease-free survival. Conclusions ER and PR status were significant predictors with staging, grading and recurrence. P53 and Ki-67 expression were inversely correlated with both ER and PR expression and have more aggressive clinicopathological features. PTEN expression was inversely correlated with PR expression but not with ER expression. The combined type of ER+PR+P53-PTEN+ was in the majority in endometrial cancer and seemed to be related to better clinical outcome. The combination of ER-PR-P53+PTEN- represented the worst disease-free survival and was strongly associated with poorest survival rate.

Potential Value of Estrogen Receptor Beta Expression in Colorectal Carcinoma: Interaction with Apoptotic Index

Prognostic Role of Estrogen Receptor Α and Estrogen Receptor Β in Gastric Cancer

Estrogen Receptor Beta Variants Mrna Expressions in Gastric Cancer Tissues and Association with Clinicopathologic Parameters

Prognostic Value of Amphiregulin and Epiregulin Mrna Expression in Metastatic Colorectal Cancer Patients

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer

Estrogen Receptor Α Variant ERα46 Mediates Growth Inhibition and Apoptosis of Human HT-29 Colon Adenocarcinoma Cells in the Presence of 17Β-Oestradiol

[Expression of Estrogen Receptor-Related Receptor Alpha and Estrogen Receptor Alpha in Endometrial Carcinoma and the Primary Investigation of Their Clinical Significance].

RETRACTED: Predictive and Prognostic Value of ER-α36 Expression in Breast Cancer Patients Treated with Chemotherapy

Prognostic Value of the Expression of Estrogen Receptor Β in Patients with Non-Small Cell Lung Cancer: a Meta-Analysis

Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer

Study on the clinical value of estrogen receptor β protein detection in fresh human breast cancer samples

Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.

Clinical Implications and Prognostic Value of Five Biomarkers in Endometrial Carcinoma

[Expression and Significance of Estrogen Receptor Isoforms in the Development of Human Breast Carcinoma].

Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance

Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis

Effect of co-expression of estrogen receptor-β and HER2 on prognosis of breast cancer

Expression of Estrogen Receptor-Related Receptor Isoforms in Endometrial Carcinoma Tissues and Its Clinical Significance

High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer

Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma

Estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background